Avid Bioservices Inc (CDMO)

[EndoTarget]

ROTH Capital Partners Senior Biotechnology Research Analysts; Joe Pantginis, Ph.D. and Elemer
Piros, Ph.D., invite you to join us for our Immuno-Oncology Corporate Access Day taking place on
Wednesday, December 16, 2015 in New York City, New York.
This event will give investors the opportunity to meet with senior management of a select group of
companies in the Immuno-Oncology sector.
Meetings will be in a 1-on-1 / small group meeting format, consisting of 45-minute managementinvestor
meetings to provide our institutional clients with extensive interaction with senior management
to gain in-depth insights into each company.
HOTEL / VENUE
Park Hyatt New York
153 West 57th Street
New York City, New York 10019 | 646.774.1234
ROTH Room Rate: $725
PARTICIPATING COMPANIES
Sponsors
Aduro BioTech, Inc. ADRO
Argos Therapeutics, Inc. ARGS
Celldex Therapeutics, Inc. CLDX
Cellectis S.A. CLLS
Galena Biopharma, Inc. GALE
ImmunoCellular Therapeutics, Ltd. IMUC
Lion Biotechnologies, Inc. LBIO
MacroGenics, Inc. MGNX
Nektar Therapeutics NKTR
Peregrine Pharmaceuticals, Inc. PPHM
Pieris Pharmaceuticals, Inc. PIRS
TG Therapeutics, Inc. TGTX
*Trillium Therapeutics Inc. TSX:TR
Subject